22 May 2013
Keywords: Pfizer, Animal health business, Spin-off, IPO, Zoetis
Article | 08 June 2012
Global drugs behemoth Pfizer (NYSE: PFE) yesterday announced the next steps in the strategic alternatives review process for the company's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.